Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 15.95 USD -2.92%
Market Cap: 1.5B USD
Have any thoughts about
Arcus Biosciences Inc?
Write Note

Arcus Biosciences Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcus Biosciences Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Arcus Biosciences Inc
NYSE:RCUS
Total Equity
$565m
CAGR 3-Years
1%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$15.6B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$29.3B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is Arcus Biosciences Inc's Total Equity?
Total Equity
565m USD

Based on the financial report for Sep 30, 2024, Arcus Biosciences Inc's Total Equity amounts to 565m USD.

What is Arcus Biosciences Inc's Total Equity growth rate?
Total Equity CAGR 5Y
26%

Over the last year, the Total Equity growth was 9%. The average annual Total Equity growth rates for Arcus Biosciences Inc have been 1% over the past three years , 26% over the past five years .

Back to Top